Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia.

Autor: Levine JE; Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, Michigan, USA.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Grupp SA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Division of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Pulsipher MA; Section of Transplantation and Cellular Therapy, Children's Hospital Los Angeles Cancer and Blood Disease Institute, University of Southern California Keck School of Medicine, Los Angeles, California, USA., Dietz AC; Section of Transplantation and Cellular Therapy, Children's Hospital Los Angeles Cancer and Blood Disease Institute, University of Southern California Keck School of Medicine, Los Angeles, California, USA., Rives S; Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu de Barcelona, Barcelona, Spain.; Institut de Recerca Sant Joan de Déu, Barcelona, Spain., Myers GD; Children's Mercy Hospital Kansas City, Kansas City, Missouri, USA., August KJ; Children's Mercy Hospital Kansas City, Kansas City, Missouri, USA., Verneris MR; Division of Pediatric Blood and Marrow Transplant, University of Minnesota, Minneapolis, Minnesota, USA.; Department of BMT and Cellular Therapy, Children's Hospital Colorado, University of Colorado, Boulder, Colorado, USA., Buechner J; Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway., Laetsch TW; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Division of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Pediatrics and Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.; Pauline Allen Gill Center for Cancer and Blood Disorders, Children's Health, Dallas, Texas, USA., Bittencourt H; Hematology Oncology Division, Charles-Bruneau Cancer Center, CHU Sainte-Justine, Montreal, Québec, Canada.; Department of Pediatrics, Faculty of Medicine, University of Montreal, Montreal, Québec, Canada., Baruchel A; Pediatric Hematology-Immunology Department, University Hospital Robert Debré (APHP) and Université de Paris, Paris, France., Boyer MW; Department of Pediatrics and Internal Medicine, University of Utah, Salt Lake City, Utah, USA., De Moerloose B; Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., Qayed M; Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, Georgia, USA., Davies SM; Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio, USA.; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Phillips CL; Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio, USA.; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Driscoll TA; Department of Pediatric Transplant and Cellular Therapy, Children's Health Center, Duke University Medical Center, Durham, North Carolina, USA., Bader P; Division for Stem Cell Transplantation and Immunology, Hospital for Children and Adolescents, University Hospital Frankfurt, Frankfurt, Germany., Schlis K; Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA., Wood PA; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Mody R; Department of Pediatrics, Division of Pediatric Hematology Oncology, Michigan Medicine, Ann Arbor, Michigan, USA., Yi L; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Leung M; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Eldjerou LK; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., June CH; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Maude SL; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA maude@chop.edu.; Division of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Aug; Vol. 9 (8).

Vitamin D effect on umbilical cord blood characteristics: a comparison between African Americans and Caucasians.

Autor: Eldjerou LK; Departments of Pediatric Blood & Marrow Transplantation, Medicine and Biostatistics, University of Florida, Gainesville, Florida., Cogle CR; Departments of Pediatric Blood & Marrow Transplantation, Medicine and Biostatistics, University of Florida, Gainesville, Florida., Rosenau EH; Departments of Pediatric Blood & Marrow Transplantation, Medicine and Biostatistics, University of Florida, Gainesville, Florida., Lu X; Departments of Pediatric Blood & Marrow Transplantation, Medicine and Biostatistics, University of Florida, Gainesville, Florida., Bennett CA; Neuroscience Program, University of Miami, Florida., Sugrue MW; Departments of Pediatric Blood & Marrow Transplantation, Medicine and Biostatistics, University of Florida, Gainesville, Florida., Hoyne J; Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, Florida., Lambert A; Michigan Blood Cord Blood Bank, Grand Rapids, Michigan., Ashley L; LifeSouth Community Blood Centers, Gainesville, Florida., Sazama K; San Diego Blood Bank Cord Blood Program, San Diego, California., Fields G; Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, Florida., Wingard JR; Departments of Pediatric Blood & Marrow Transplantation, Medicine and Biostatistics, University of Florida, Gainesville, Florida., Zubair AC; Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, Florida.

Publikováno v: Transfusion [Transfusion] 2015 Jul; Vol. 55 (7), pp. 1766-71. Date of Electronic Publication: 2015 Apr 22.

Late effects in hematopoietic cell transplant recipients with acquired severe aplastic anemia: a report from the late effects working committee of the center for international blood and marrow transplant research.

Autor: Buchbinder D; Department of Hematology, Children's Hospital of Orange County, Orange, California, USA., Nugent DJ, Brazauskas R, Wang Z, Aljurf MD, Cairo MS, Chow R, Duncan C, Eldjerou LK, Gupta V, Hale GA, Halter J, Hayes-Lattin BM, Hsu JW, Jacobsohn DA, Kamble RT, Kasow KA, Lazarus HM, Mehta P, Myers KC, Parsons SK, Passweg JR, Pidala J, Reddy V, Sales-Bonfim CM, Savani BN, Seber A, Sorror ML, Steinberg A, Wood WA, Wall DA, Winiarski JH, Yu LC, Majhail NS

Publikováno v: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2012 Dec; Vol. 18 (12), pp. 1776-84. Date of Electronic Publication: 2012 Aug 01.